BMRN - BioMarin Pharmaceutical, Inc.
This page shows which of the focused investors we track hold BMRN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 4 managers with an aggregate reported value of $1.28B, which is 0.12% of the combined portfolio.
As of Q1 2026, 4 tracked institutional managers held BMRN (BioMarin Pharmaceutical, Inc.) with an aggregate reported value of $1.28B — 0.12% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BMRN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- BMRN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 0.45% | Reduce -0.1% | 14,561,759 | $822.59M |
| 2 | Viking Global Investors - Viking Global Investors | 1.12% | Add +17.0% | 7,062,077 | $398.94M |
| 3 | Torray Funds - Torray Funds | 0.65% | New | 78,170 | $4.42M |
Other instruments
Bonds, warrants, or other non-share-class principal positions in BMRN.
| 1 | Howard Marks - Oaktree Capital Management | Add +32.9% | 55,985,000 | $54.02M |
Loading holder history for BMRN…